Published in Biochim Biophys Acta on February 29, 1972
A salt bridge stabilizes the helix formed by isolated C-peptide of RNase A. Proc Natl Acad Sci U S A (1982) 2.71
Chemical modification by pyridoxal 5'-phosphate and cyclohexane-1,2-dione indicates that Lys-7 and Arg-10 are involved in the p2 phosphate-binding subsite of bovine pancreatic ribonuclease A. Biochem J (1990) 0.87
Structure and enzymic activity of ribonuclease-A esterified at glutamic acid-49 and aspartic acid-53. Biochem J (1978) 0.75
Structure of TPR domain-peptide complexes: critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine. Cell (2000) 7.25
A gated channel into the proteasome core particle. Nat Struct Biol (2000) 5.42
Mutational studies on HslU and its docking mode with HslV. Proc Natl Acad Sci U S A (2000) 1.79
The substrate specificity of the protein kinase induced in cells infected with herpesviruses: studies with synthetic substrates [corrected] indicate structural requirements distinct from other protein kinases. Biochim Biophys Acta (1986) 1.71
An investigation of the substrate specificity of protein phosphatase 2C using synthetic peptide substrates; comparison with protein phosphatase 2A. Biochim Biophys Acta (1990) 1.56
[Di-tert.-butyl-dicarbonate, a useful tert.-Butyloxycardonylating reagent (author's transl)]. Hoppe Seylers Z Physiol Chem (1976) 1.48
Site specificity of casein kinase-2 (TS) from rat liver cytosol. A study with model peptide substrates. Eur J Biochem (1986) 1.43
Further definition of the substrate specificity of the alpha-herpesvirus protein kinase and comparison with protein kinases A and C. Biochim Biophys Acta (1991) 1.41
Sulfenyl halides as modifying reagents for polypeptides and proteins. I. Modification of tryptophan residues. Biochemistry (1968) 1.41
Radioiodine is an effective, inexpensive, and safe treatment for Graves' hyperthyroidism, its immunological effects must be taken into account. J Endocrinol Invest (1999) 1.39
The substrate translocation channel of the proteasome. Biochimie (2001) 1.29
A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology (1999) 1.26
Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab (2001) 1.23
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery (1996) 1.17
Selective and reversibe photo-oxidation of the methionyl residues in lysozyme. J Biol Chem (1968) 1.11
Synthetic peptides including acidic clusters as substrates and inhibitors of rat liver casein kinase TS (type-2). J Biol Chem (1984) 1.11
Partial retro-inverso analogues of somatostatin: pairwise modifications at residues 7 and 8 and at residues 8 and 9. Biochemistry (1985) 1.08
Sulfenyl halides as modifying reagents for polypeptides and proteins. 3. Azobenzene-2-sulfenyl bromide, a selective reagent for cysteinyl residues. Biochemistry (1968) 1.07
Sarcolipin, the shorter homologue of phospholamban, forms oligomeric structures in detergent micelles and in liposomes. J Biol Chem (2001) 1.06
Atomic mutations at the single tryptophan residue of human recombinant annexin V: effects on structure, stability, and activity. Biochemistry (1999) 1.05
Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. Neurology (2002) 1.04
Design and synthesis of heterotrimeric collagen peptides with a built-in cystine-knot. Models for collagen catabolism by matrix-metalloproteases. FEBS Lett (1996) 1.04
Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid (1997) 1.03
The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme. Eur J Biochem (1992) 1.00
Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state. J Biol Chem (1998) 1.00
Synthesis and conformational analysis of apamin analogues with natural and non-natural cystine/selenocystine connectivities. Biopolymers (2000) 1.00
Unusual properties of the fungal conventional kinesin neck domain from Neurospora crassa. EMBO J (2001) 1.00
Photomodulation of conformational states. I. Mono- and bicyclic peptides with (4-amino)phenylazobenzoic acid as backbone constituent. Biopolymers (2000) 1.00
Dephosphorylation of phosphoproteins and synthetic phosphopeptides. Study of the specificity of the polycation-stimulated and MgATP-dependent phosphorylase phosphatases. J Biol Chem (1987) 0.99
Dye-sensitized selective photooxidation of methionine. Biochim Biophys Acta (1968) 0.99
Synthetic peptide substrates for casein kinase 2. Assessment of minimum structural requirements for phosphorylation. Biochim Biophys Acta (1988) 0.98
Electrical stimulation of human femoral intertrochanteric osteotomies. Double-blind study. Clin Orthop Relat Res (1988) 0.98
Enkephalin-induced inhibition of cortical neurones and the lack of this effect in morphine tolerant/dependent rats. Brain Res (1976) 0.98
The electrical stimulation of tibial osteotomies. Double-blind study. Clin Orthop Relat Res (1993) 0.97
Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes. Chem Biol (1999) 0.97
Synthesis of selenocysteine peptides and their oxidation to diselenide-bridged compounds. J Pept Sci (1998) 0.97
Bivalency as a principle for proteasome inhibition. Proc Natl Acad Sci U S A (1999) 0.96
Fast intracellular pH determination in single cells by flow-cytometry. Naturwissenschaften (1981) 0.96
Distinct structural requirements of Ca2+/phospholipid-dependent protein kinase (protein kinase C) and cAMP-dependent protein kinase as evidenced by synthetic peptide substrates. FEBS Lett (1985) 0.96
Specificity of T-cell protein tyrosine phosphatase toward phosphorylated synthetic peptides. Eur J Biochem (1993) 0.96
Synthesis of beta-(1-azulenyl)-L-alanine as a potential blue-colored fluorescent tryptophan analog and its use in peptide synthesis. J Pept Sci (2000) 0.95
Cytochrome c chimerae from natural and synthetic fragments: significance of the biological properties. Biopolymers (1986) 0.94
Intervesicle cross-linking with integrin alpha IIb beta 3 and cyclic-RGD-lipopeptide. A model of cell-adhesion processes. Biochemistry (2000) 0.94
Photomodulation of conformational states. Synthesis of cyclic peptides with backbone-azobenzene moieties. J Pept Sci (1999) 0.94
Atomic mutations in annexin V--thermodynamic studies of isomorphous protein variants. Eur J Biochem (1998) 0.94
Conformational studies on polypeptides. The effect of sodium perchlorate on the conformation of poly-L-lysine and of random copolymers of L-lysine and L-phenylalanine in aqueous solution. Biopolymers (1972) 0.94
Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin. Protein Sci (1999) 0.94
The influence of secretin, glucagon and other peptides, of amino acids, prostaglandin endoperoxide analogues and diazepam on the level of adenosine 3',5'-cyclic monophosphate in neuroblastoma x glioma hybrid cells. J Neurochem (1979) 0.93
Bioincorporation of telluromethionine into proteins: a promising new approach for X-ray structure analysis of proteins. J Mol Biol (1997) 0.93
Synthetic peptides as model substrates for the study of the specificity of the polycation-stimulated protein phosphatases. Eur J Biochem (1990) 0.93
Redox potentials of active-site bis(cysteinyl) fragments of thiol-protein oxidoreductases. Biochemistry (1993) 0.93
Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin. J Biol Chem (1999) 0.92
Studies on polypeptides. XLV. Structure-function studies in the beta-corticotropin series. J Med Chem (1970) 0.92
Mutation of Asn-391 within the conserved NPXXY motif of the cholecystokinin B receptor abolishes Gq protein activation without affecting its association with the receptor. J Biol Chem (2000) 0.92
Substrate-specificity determinants for a membrane-bound casein kinase of lactating mammary gland. A study with synthetic peptides. Eur J Biochem (1988) 0.92
Reversible acetoacetylation of amino groups in proteins . Biochim Biophys Acta (1968) 0.91
Activation of snake venom metalloproteinases by a cysteine switch-like mechanism. FEBS Lett (1993) 0.91
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. J Clin Endocrinol Metab (1998) 0.91
Synthesis of peptide analogs of the N-terminal eicosapeptide sequence of ribonuclease A. VII. Synthesis of ile, orn -and ala, orn -eicosapeptides. J Am Chem Soc (1967) 0.89
Photomodulation of conformational states. II. Mono- and bicyclic peptides with (4-aminomethyl)phenylazobenzoic acid as backbone constituent. Biopolymers (2000) 0.89
The disulfide-coupled folding pathway of apamin as derived from diselenide-quenched analogs and intermediates. Protein Sci (1999) 0.89
Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord (2012) 0.89
Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin. J Biol Chem (1997) 0.89
Heterotrimeric collagen peptides as fluorogenic collagenase substrates: synthesis, conformational properties, and enzymatic digestion. Biochemistry (2000) 0.89
Toward a high-resolution structure of phospholamban: design of soluble transmembrane domain mutants. Biochemistry (2000) 0.88
Orbital radiotherapy for Graves' ophthalmopathy. Thyroid (1998) 0.88
1-(tert-butylthio)-1,2-hydrazinedicarboxylic acid derivatives. New reagents for the introduction of the S-tert-butylthio group into cysteine and cysteine derivatives. Hoppe Seylers Z Physiol Chem (1982) 0.88
An exploration of the effects of constraints on the phosphorylation of synthetic protein tyrosine kinase peptide substrates. J Pept Sci (1997) 0.88
The natural human IgG anti-F(ab')2 antibody recognizes a conformational IgG1 hinge epitope. J Immunol (1995) 0.88
Ca2+ phospholipid-dependent and independent phosphorylation of synthetic peptide substrates by protein kinase C. Eur J Biochem (1987) 0.88
Molecular structure of the cyanobacterial tumor-promoting microcystins. FEBS Lett (1994) 0.87
Ultrafast conformational dynamics in cyclic azobenzene peptides of increased flexibility. Biophys J (2004) 0.87
Isomorphous replacement of cystine with selenocystine in endothelin: oxidative refolding, biological and conformational properties of [Sec3,Sec11,Nle7]-endothelin-1. J Mol Biol (1998) 0.87
Vascular remodeling after carotid artery stenting. Angiology (2007) 0.86
Anthrax in animals and a farmer in Alto Adige, Italy. Euro Surveill (2006) 0.86
Threonine(6)-bradykinin: conformational study of a flexible peptide in dimethyl sulfoxide by NMR and ensemble calculations. Biopolymers (1996) 0.86
Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V. Proc Natl Acad Sci U S A (1998) 0.85
[Occupational accidents in temporary work]. Med Lav (2001) 0.85
Drinking in a patchy environment: the effect of the price of water. J Exp Anal Behav (1994) 0.85
(4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase. Proc Natl Acad Sci U S A (2000) 0.85
Review of 1600 water births. Does water birth increase the risk of neonatal infection? J Matern Fetal Neonatal Med (2005) 0.85
Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin. FEBS Lett (1983) 0.84
Proteins with beta-(thienopyrrolyl)alanines as alternative chromophores and pharmaceutically active amino acids. Protein Sci (2001) 0.84
Conformational studies of equilibrium structures in fragments of horse heart cytochrome c. Eur J Biochem (1975) 0.84
Chalcogen-analogs of amino acids. Their use in X-ray crystallographic and folding studies of peptides and proteins. Biol Chem (1997) 0.84
Analytical solution to the Lipari-Szabo model based on the reduced spectral density approximation offers a novel protocol for extracting motional parameters. J Magn Reson (2001) 0.83
New synthesis of somatostatin according to the S-tert-butylthiocysteine procedure. Biopolymers (1981) 0.83
Conformational analysis of a IgG1 hinge peptide derivative in solution determined by NMR spectroscopy and refined by restrained molecular dynamics simulations. Biopolymers (1991) 0.83
Glycodermorphins: opioid peptides with potent and prolonged analgesic activity and enhanced blood-brain barrier penetration. Br J Pharmacol (1998) 0.83
Evidence for a direct interaction between the penultimate aspartic acid of cholecystokinin and histidine 207, located in the second extracellular loop of the cholecystokinin B receptor. J Biol Chem (1999) 0.83